Company / Net Income
Incyte Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$1.3B
FY2025
5-year range
$32.6M / $1.3B
FY2021-FY2025
Trend
+3845.0%
vs FY2024
Sector context
#17 of 216
Health Care
What the data says
Net Income changed +3845% YoY in FY2025, a notable deviation from the 9-year average annual change of +446%.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +63.7%. Top quartile in the Health Care sector.
Improved from $598M to $1.3B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +55.7%
- 5-Year CAGR
- +63.7%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 216This company $1.3B Sector average $454.3M
▼
+183.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +63.7%, indicating consistent growth.
- In FY2025, net income increased 3845.0% year-over-year.
- Ranks #17 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +3845.0% |
| FY2024 | $32.6M | -94.5% |
| FY2023 | $597.6M | +75.4% |
| FY2022 | $340.7M | -64.1% |
| FY2021 | $948.6M | +766.3% |
| FY2020 | $109.5M | +135.0% |
| FY2019 | -$313.1M | -386.0% |
| FY2018 | $109.5M | +135.0% |
| FY2017 | -$313.1M | -400.5% |
| FY2016 | $104.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026